Lind Global Fund II LP 13D and 13G filings for China SXT Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-13 4:28 pm Unchanged |
2022-12-31 | 13G | China SXT Pharmaceuticals, Inc. SXTC |
Lind Global Fund II LP | 0 0.000% |
0 (Unchanged) |
Filing |